EMA Authorised: Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop) (irbesartan;hydrochlorothiazide) — sanofi-aventis groupe

View source ↗

Summary

Authorised fixed-dose combination of irbesartan and hydrochlorothiazide for hypertension in the EU.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Irbesartan Hydrochlorothiazide Zentiva (irbesartan/hydrochlorothiazide)

Snippet

Status: Authorised. Therapeutic area: Hypertension. MAH: sanofi-aventis groupe. Decision date: 31/07/2026